Malignant pleural mesothelioma following radiotherapy for Hodgkin's disease;Mesotheliome malin de la plevre apres irradiation pour maladie de Hodgkin

Bulletin du Cancer

Volumn 83, Issue 11, 1996, Pages 964-968

  Falchero, L ^a,e   Coiffier, B ^b   Guibert, B ^c   Souquet, P J ^d   Isaac Pinet, S ^e   Trillet Lenoir, V ^a  

^a Service de Radiolhérapie oncologie   (France)

^b Service d'Hematologie Clinique   (France)

^c Service de Chirurgie Thoracique   (Lebanon)

^d Service de Pneumologie   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Hodgkin's disease; mesothelioma; radiotherapy; second neoplasms

Indexed keywords

CHLORMETHINE; PREDNISONE; PROCARBAZINE; VINCRISTINE; ANTINEOPLASTIC AGENT; MOPP PROTOCOL;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; PLEURA MESOTHELIOMA; RADIOTHERAPY; CASE REPORT; FOLLOW UP; MESOTHELIOMA; MIDDLE AGED; PATHOLOGY; PLEURA TUMOR; RADIATION INJURY; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; MECHLORETHAMINE; MESOTHELIOMA; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; PLEURAL NEOPLASMS; PREDNISONE; PROCARBAZINE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0030278131     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Anderson KA, Hurley WC,' Hurley BT, Ohrt DW. Malignant pleural mesothelioma following radiotherapy in a 16 year-old boy. Cancer 1985;56:273-6
2. Antman KH, Corson JM, Li FP, Sytkowski A, Henson DE, Weinstein L. Malignant mesothelioma following radiation exposure. J Clin Oncol 1983; 1:695-700
3. Antman KH, Ruxer RL, Aisner J, Vawter G. Mesothelioma following Wilm's tumor in childhood. Cancer 1984;54:367-9
4. Austin MB, Fechner RE, Roggli VL. Pleural malignant mesothelioma following Wilm's tumor. Am J Clin Palhol 1986;86:227-30
5. Boivin JF, Hutchison OB, Zauber AG et al. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 1995;87:732-41
6. Brenner J, Sordillo PP, Magill CD, Goibey RB. Malignant mesothelioma of the pleura: review of 123 patients. Cancer 1982;49:2431-5
7. Brody RS, Schottenfeld D, Reid A. Multiple primary cancer risk after therapy for Hodgkin's disease. Cancer 1977;40: 1917-26
8. Cahan WG, Woodward HQ, Higinbotham NL, Stewart FW, Coley BL. Sarcoma arising in irradiated bone: report of eleven cases. Cancer 1948;1:3-29
9. Cavazza A, Travis LB, Travis WD et al. Post-irradiation malignant mesothelioma. Cancer 1996;77:1379-85
10. Committee on the Biologic Effects of Ionizing Radiations (BEIR V), National Research Council. Health effects of exposure to low levels of ionizing radiation. Washington, DC: National Academy Press, 1990
11. Dietrich PY, Henry-Amar M, Cosset JM, Bodis S, Bosq J, Hayat M. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? Blood 1994;84:1209-15
12. Efremidis AP, Waxman JS, Chahinian P. Association of lymphocytic neoplasia and mesothelioma. Cancer 1985;55: 1056-9
13. Gilks B, Hegebdus C, Freeman H, Fratkin L, Churg A. Malignant peritoneal mesothelioma after remote abdominal radiation. Cancer 1988;61:2019-21
14. Henry-Amar M. Second cancer after the treatement for Hodgkin's disease. A report from the International Data-base on Hodgkin's disease. Ann Oncol 1992;3:117-28
15. Hofmann J, Mintzer D, Warhol MJ. Malignant mesothelioma following radiation therapy. Am J Med 1994;97: 379-82
16. Hone A, Hiraoka K, Yamamoto O, Haratake J, Tsuchiya T, Sugimoto H. An autopsy case of peritoneal malignant mesothelioma in a radiation technologist. Ada Pathol Jpn 1990;40:57-62
17. Jawien J, Prokop A. Heart failure, recurrent ventricular fibrillations and pleura! mesothelioma in a young man who was treated in chilhood with radiotherapy for Hodgkin's disease. Pol Arch Med Wewn 1993;90:287-90
18. Kaldor JM, Day NE, Clarke EA et al. Leukemia following Hodgkin's disease. N Engl J Med 1990;7:322-13
19. Kawashima A, Libshitz HI, Lukeman JM. Radiation-induced malignant pleural mesothelioma. Can Assoc Radial J 1990:41:384-6
20. Lerman Y, Learman Y, Pinhas S, Herceg E, Lieberman Y, Yellin A. Radiation associated malignant pleural mesothelioma. Thorax 1991;46:463-4
21. Levy R, Le Maignan C, Andrieu JM. Mésothéliome après radiothérapie pour maladie de Hodgkin. Bull Cancer 1995; 82:464-5
22. Li FP. Second malignant tumor after cancer in childhood. Cancer 1977:40:1899-902
23. Nebut M, Delepierre F, Bignon J. Mésothéliomes. Encycl Méd-CMr (Eisevier, Paris). Poumon, 6002 H 104-1984
24. Peterson JT, Greenberg SD, Buffler PA. Non-asbestos-related malignant mesothelioma. Cancer 1984;54:951-60
25. Ruffie P, Feld R, Minkin S et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989;7:1157-68
26. Shannon VR, Nesbitt JC, Libshitz H. Malignant pleural mesothelioma after radiation therapy for breast cancer. Cancer 1995;76:437-41
27. Tester WJ, Kinsella TJ, Waller B et al. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. J Clin Oncol 1984;2:762-9
28. Tucker MA, Caggana M, Kelsey K, Coleman CN. Secondary cancers. In: De Vita VT, Hellman S, Rosenberg SA,
29. eds. Cancer. Principles and practice of oncology. Philadelphia: Lippincott, 1993:2402-15
30. Tura S, Fiacchini M, Zinzani PL, Brusamolino E, Gobbi PG. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol 1993;11: 925-30
31. Urba WJ, Longo DL. Hodgkin's disease. N Engl J Med 1992;326:678-87
32. Van Leeuwen FE, Chorus AMI, Van den Belt-Dusebout AW et al. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 1994; 12:1063-73
33. Van Leeuwen FE, Klokman WJ, Hagenbeek A et al. Second cancer risk following Hodgkin's disease: a 20 year follow-up study. J Clin Oncol 1994; 12:312-25